Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Garber

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
American Journal of Human Genetics|September 1, 1996
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2T R Rebbeck, F J Couch, J Kant, et al.
Annals of Surgical Oncology|October 1, 2010
Does neoadjuvant bevacizumab increase surgical complications in breast surgery?M Golshan, J E Garber, R Gelman, et al.
JAMA|August 11, 2000
Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polypsS Syngal, D Schrag, M Falchuk, et al.
Cancer|December 15, 1990
Choroid plexus tumors in the breast cancer-sarcoma syndromeJ E Garber, E M Burke, B L Lavally, et al.
Progress in Clinical and Biological Research|January 1, 1997
Defining etiologic heterogeneity in breast cancer using genetic biomarkersT R Rebbeck, A H Walker, C M Phelan, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Carcinoembryonic antigen in breast nipple aspirate fluidL Foretova, J E Garber, N L Sadowsky, et al.
Journal of the National Cancer Institute|August 15, 1992
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individualsF P Li, J E Garber, S H Friend, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
American Journal of Human Genetics|September 1, 1996
Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2T R Rebbeck, F J Couch, J Kant, et al.
Annals of Surgical Oncology|October 1, 2010
Does neoadjuvant bevacizumab increase surgical complications in breast surgery?M Golshan, J E Garber, R Gelman, et al.
JAMA|August 11, 2000
Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polypsS Syngal, D Schrag, M Falchuk, et al.
Cancer|December 15, 1990
Choroid plexus tumors in the breast cancer-sarcoma syndromeJ E Garber, E M Burke, B L Lavally, et al.
Progress in Clinical and Biological Research|January 1, 1997
Defining etiologic heterogeneity in breast cancer using genetic biomarkersT R Rebbeck, A H Walker, C M Phelan, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1998
Carcinoembryonic antigen in breast nipple aspirate fluidL Foretova, J E Garber, N L Sadowsky, et al.
Journal of the National Cancer Institute|August 15, 1992
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individualsF P Li, J E Garber, S H Friend, et al.
Pageof 8